In 2023, Taiyen Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Taiyen Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 |
|---|---|---|
Total Scope 1 | 24,563a | 24,318a |
Total Scope 2 | ||
Unspecified Calculation Method | 893a | 1,003a |
Total Scope 3 | N/A | N/A |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 221.0501a | 206.7927a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2023, the total operational greenhouse gas (GHG) emissions of Taiyen Biotech amounted to 25,456 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Taiyen Biotech increased by 0.53%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2023, the total Scope 1 emissions of Taiyen Biotech were 24,563 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2022), Taiyen Biotech's Scope 1 emissions increased by 1.01%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2023, Taiyen Biotech reported Scope 2 greenhouse gas (GHG) emissions of 893 tCO₂e without specifying the calculation method.a
Compared to the previous year (2022), Taiyen Biotech's Scope 2 emissions (Unspecified Calculation Method) fell by 10.97% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a
In 2023, Taiyen Biotech reported its Scope 2 emissions using an unspecified methodology.a
In 2023, Taiyen Biotech reported Scope 1 greenhouse gas (GHG) emissions of 24,563 tCO₂e and total revenues of USD 111 millions. This translates into an emissions intensity of 221.05 tCO₂e per millions USD.a
In 2023, Taiyen Biotech reported a Scope 1 emissions intensity of 221.05 tCO₂e per millions USD. Compared to the peer group median of 8.79, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2023, Taiyen Biotech ranked 26 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Taiyen Biotech among the least efficient performers, with one of the highest emissions intensities in its sector.a